75834-133-05 |
75834-133 |
HUMAN PRESCRIPTION DRUG |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE |
ORAL |
20170904 |
N/A |
ANDA |
ANDA203844 |
Nivagen Pharmaceuticals, Inc. |
RIVASTIGMINE TARTRATE |
1.5 mg/1 |
500 CAPSULE in 1 BOTTLE, PLASTIC (75834-133-05) |
75834-133-60 |
75834-133 |
HUMAN PRESCRIPTION DRUG |
RIVASTIGMINE TARTRATE |
RIVASTIGMINE TARTRATE |
CAPSULE |
ORAL |
20170904 |
N/A |
ANDA |
ANDA203844 |
Nivagen Pharmaceuticals, Inc. |
RIVASTIGMINE TARTRATE |
1.5 mg/1 |
60 CAPSULE in 1 BOTTLE, PLASTIC (75834-133-60) |
71209-012-03 |
71209-012 |
HUMAN PRESCRIPTION DRUG |
Rivastigmine Tartrate |
Rivastigmine Tartrate |
CAPSULE |
ORAL |
20140211 |
N/A |
ANDA |
ANDA203844 |
Cadila Pharmaceuticals Limited |
RIVASTIGMINE TARTRATE |
1.5 mg/1 |
60 CAPSULE in 1 BOTTLE (71209-012-03) |
71209-012-10 |
71209-012 |
HUMAN PRESCRIPTION DRUG |
Rivastigmine Tartrate |
Rivastigmine Tartrate |
CAPSULE |
ORAL |
20140211 |
N/A |
ANDA |
ANDA203844 |
Cadila Pharmaceuticals Limited |
RIVASTIGMINE TARTRATE |
1.5 mg/1 |
500 CAPSULE in 1 BOTTLE (71209-012-10) |